Ondine Biomedical to Present Nasal Photodisinfection at the 5th International Conference on Prevention & Infection Control (ICPIC 2019)
September 09, 2019 08:00 ET | Ondine Biomedical Inc.
Vancouver, Canada, Sept. 09, 2019 (GLOBE NEWSWIRE) -- Ondine announces that Dr. Nicolas Loebel will address the 5th International Conference on Prevention & Infection Control (ICPIC) held in...
Ondine Biomedical Inc. to Present Candida auris Program Results at the 5th International Conference on Prevention & Infection Control (ICPIC, 2019, Geneva)
September 06, 2019 11:37 ET | Ondine Biomedical Inc.
Vancouver, Canada, Sept. 06, 2019 (GLOBE NEWSWIRE) -- Ondine Biomedical Inc. announces presentation of data demonstrating high levels of efficacy of its Photodisinfection program against Candida...
Ondine Biomedical’s Nasal Photodisinfection is Selected as a Top Innovation of the Year
July 29, 2019 08:00 ET | Ondine Biomedical Inc.
Vancouver, Canada, July 29, 2019 (GLOBE NEWSWIRE) -- The Infection Prevention Strategy (TIPS) today announced Ondine Biomedical Inc.’s nasal Photodisinfection among the winners of the TIPS Top...
Ondine Biomedical Introduces Nasal Photodisinfection to Quebec through MAM Medical Inc.
April 29, 2019 06:00 ET | Ondine Biomedical Inc.
Vancouver, BC, Canada, April 29, 2019 (GLOBE NEWSWIRE) -- Ondine Biomedical Inc. announced today it has entered into an exclusive agency agreement with MAM Medical Inc. to represent Ondine’s...
Multidrug-Resistant Candida auris and Aspergillus fumigatus Eradicated by Ondine Biomedical’s antimicrobial Photodisinfection
April 10, 2019 16:25 ET | Ondine Biomedical Inc.
Vancouver, BC Canada, April 10, 2019 (GLOBE NEWSWIRE) -- Ondine Biomedical Inc. announced today that its antimicrobial Photodisinfection Therapy (aPDT) successfully eradicated in laboratory testing...
Global charity discovers superbugs in pork products
December 19, 2018 08:00 ET | World Animal Protection
Toronto, ON, Dec. 19, 2018 (GLOBE NEWSWIRE) -- Bacteria that is resistant to antibiotics most critically important to humans, has been found in pork from supermarket shelves in Brazil, Spain and...
Summit Master_rgb_png.png
Summit Discovers Multiple New Mechanism Antibiotics Against Novel ESKAPE Pathogen Targets
September 06, 2018 07:00 ET | Summit Therapeutics plc
Summit Therapeutics plc  (‘Summit’ or the ’Company’)Summit Discovers Multiple New Mechanism Antibiotics Against Novel ESKAPE Pathogen Targets Discovery Enabled by Discuva Platform and...
ContraFect_LOGO_Web.jpg
ContraFect to Present at the 20th Annual Superbugs & Superdrugs UK Conference
March 14, 2018 07:00 ET | ContraFect Corporation
YONKERS, New York, March 14, 2018 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq:CFRX), a clinical-stage biotechnology company focused on the discovery and development of protein and antibody...
email logo (003).png
Avivagen Announces Presentation at the Bloom Burton & Co. Healthcare Investor Conference on May 2, 2017
April 26, 2017 15:28 ET | Avivagen Inc.
OTTAWA, April 26, 2017 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (OTC Pink:CHEXF) (Avivagen or the Corporation), a company with a proven and commercially-ready, patent-protected product...
email logo (003).png
Avivagen Announces Results From Its Annual and Special Meeting of Shareholders
April 12, 2017 09:26 ET | Avivagen Inc.
OTTAWA, April 12, 2017 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (OTC Pink:CHEXF) (Avivagen or the Corporation), a Corporation with a proven and commercially-ready, patent-protected product...